Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Atlas Venture Fund XI, L.P. DYN Dyne Therapeutics, Inc. 13G/A 2.4% 3mo
WELLINGTON MANAGEMENT GROUP LLP UTHR UNITED THERAPEUTICS Corp 13G/A 3.2% 3mo
Artisan Partners Limited Partnership ST Sensata Technologies Holding plc 13G/A 0% 3mo
Mizuho Financial Group, Inc. MKLY McKinley Acquisition Corp 13G 5.3% 3mo
Conifer Management, L.L.C. GPI Group 1 Automotive Inc 13G/A 8.1% 3mo
Long Pond Capital, LP IRT Independence Realty Trust, Inc. 13G/A 2.18% 3mo
Soleus Capital Master Fund, L.P. RIGL Rigel Pharmaceuticals Inc 13G/A 9.9% 3mo
AQR CAPITAL MANAGEMENT LLC NNN Nnn REIT, Inc. 13G 5.14% 3mo
Magnetar Financial LLC WLCO Wilco 63 Corp 13G 7.83% 3mo
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC TTAN ServiceTitan, Inc. 13G/A 4.5% 3mo
Deerfield Management Company, L.P. COGT Cogent Biosciences, Inc. 13G/A 2.88% 3mo
Wolf Hill Capital Management, LP NN Nextnav Inc. 13G/A 2.1% 3mo
Conifer Management, L.L.C. AIIR AIR Global PLC 13G 6% 3mo
Invesco Ltd. WT WisdomTree, Inc. 13G 6.6% 3mo
WELLINGTON MANAGEMENT GROUP LLP KFY Korn Ferry 13G/A 5% 3mo
Sands Capital Life Sciences Pulse Fund II. L.P. IKT Inhibikase Therapeutics, Inc. 13G/A 9.3% 3mo
BAIRD ROBERT W & CO INC /WI/ FCAL First Trust Exchange-Traded Fund III 13G/A 4.8% 3mo
Mizuho Financial Group, Inc. CRAC Crown Reserve Acquisition Corp. I 13G 6.6% 3mo
BARCLAYS PLC PCAP ProCap Acquisition Corp 13G 7% 3mo
RENAISSANCE TECHNOLOGIES LLC PETS Petmed Express Inc 13G/A 5.29% 3mo
Centiva Capital, LP PCAP ProCap Acquisition Corp 13G/A 1.5% 3mo
Affinity Asset Advisors, LLC NXTC NextCure, Inc. 13G/A 6.4% 3mo
BARCLAYS PLC OPI Office Properties Income Trust 13G 8.43% 3mo
Rodney Hodges HLSQ Tessera Defense & Homeland Security Inc. 13G/A 0.7% 3mo
HITE Hedge Asset Management LLC KRSP Rice Acquisition Corp 3 13G 6.67% 3mo
WELLINGTON MANAGEMENT GROUP LLP CGON CG Oncology, Inc. 13G/A 6% 3mo
BARCLAYS PLC PEN Penumbra Inc 13G 5.95% 3mo
Theofilos Charles Steve ECOR electroCore, Inc. 13G/A 9.9% 3mo
Invesco Ltd. HIVE HIVE Digital Technologies Ltd. 13G/A 6.4% 3mo
VAN ECK ASSOCIATES CORP AGI Alamos Gold Inc 13G/A 8.5% 3mo
Lovett William Radford II DFH Dream Finders Homes, Inc. 13G/A 9.7% 3mo
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC NRC Nrc Health 13G/A 9% 3mo
GLAZER CAPITAL, LLC SUMA SUMA Acquisition Corp 13G/A 6.24% 3mo
GLAZER CAPITAL, LLC AACP Apogee Acquisition Corp 13G 5.45% 3mo
GLAZER CAPITAL, LLC THR Thermon Group Holdings, Inc. 13G/A 0% 3mo
MOHNISH PABRAI AMR Alpha Metallurgical Resources, Inc. 13G/A 4.76% 3mo
WELLINGTON MANAGEMENT GROUP LLP CRNX Crinetics Pharmaceuticals, Inc. 13G/A 6.8% 3mo
Kore Advisors LP UP Wheels Up Experience Inc. 13G/A 2.12% 3mo
WELLINGTON MANAGEMENT GROUP LLP BUSE First Busey Corp 13G/A 5.8% 3mo
Mizuho Financial Group, Inc. MACI Melar Acquisition Corp. I 13G/A 0% 3mo
ASHFORD CAPITAL MANAGEMENT INC VOXR Vox Royalty Corp. 13G/A 4.9% 3mo
WELLINGTON MANAGEMENT GROUP LLP MYFW First Western Financial Inc 13G/A 7.7% 3mo
Magnetar Financial LLC CXII Churchill Capital Corp XII 13G 6.47% 3mo
WELLINGTON MANAGEMENT GROUP LLP CYTK Cytokinetics Inc 13G/A 5.1% 3mo
WELLINGTON MANAGEMENT GROUP LLP ARES Ares Management Corp 13G/A 4.3% 3mo
Invesco Ltd. BSCA Invesco Exchange-Traded Self-Indexed Fund Trust 13G/A 21.9% 3mo
Artisan Partners Limited Partnership TWST Twist Bioscience Corp 13G/A 7.7% 3mo
BAIRD ROBERT W & CO INC /WI/ BD Russell Investments Exchange Traded Funds 13G 5.6% 3mo
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC OFLX Omega Flex, Inc. 13G/A 4.5% 3mo
AQR CAPITAL MANAGEMENT LLC GIX GigCapital9 Corp. 13G/A 5.74% 3mo